SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from KALA BIO, (KALA) — Feb 13, 2026

KALA BIO, Inc.
Date: Feb. 13, 2026 · CIK: 0001479419 · Accession: 0001829126-26-001315

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-293323

Date
February 10, 2026
Author
Chief
Form
CORRESP
Company
KALA BIO, Inc.

Letter

KALA BIO, Inc.

Massachusetts Avenue

Arlington, MA 02476

February 13, 2026

VIA EDGAR

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

Washington, D.C. 20549

Attention: Tim Buchmiller

Re: KALA BIO, Inc. Registration Statement on Form S-3 Originally filed on February 10, 2026 File No. 333-293323 (the " Registration Statement ") Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the " Commission ") under the Securities Act of 1933, as amended, KALA BIO, Inc. (the " Company "), hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on February 17, 2026, or as soon thereafter as practicable.

Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Bruce Newsome, Esq. at (214) 651.5119.

Very
truly yours,
KALA
BIO, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 KALA
BIO, Inc.

 1167
Massachusetts Avenue

 Arlington,
MA 02476

 February
13, 2026

 VIA EDGAR

 Division of Corporation Finance

 Office of Life Sciences

 U.S. Securities and Exchange Commission

 Washington, D.C. 20549

 Attention:
Tim Buchmiller

 Re:
 KALA
 BIO, Inc.
 Registration
 Statement on Form S-3
 Originally
 filed on February 10, 2026
 File
 No. 333-293323 (the " Registration Statement ")
 Request
 for Acceleration

 Ladies
and Gentlemen:

 Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the " Commission ") under
the Securities Act of 1933, as amended, KALA BIO, Inc. (the " Company "), hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 4:00 p.m., Eastern Time, on February 17, 2026,
or as soon thereafter as practicable.

 Should
any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes
and Boone, LLP, attention: Bruce Newsome, Esq. at (214) 651.5119.

 Very
 truly yours,

 KALA
 BIO, Inc.

 By:
 /s/
 Avi Minkowitz

 Avi
 Minkowitz

 Chief
 Executive Officer

 cc:
 Bruce
 Newsome, Esq., Haynes and Boone, LLP